Geneva Health Files

Share this post

Regulatory discoherence: The case of remdesivir; WTO TRIPS Waiver informals

genevahealthfiles.substack.com

Regulatory discoherence: The case of remdesivir; WTO TRIPS Waiver informals

Newsletter Edition #14

Priti Patnaik
Dec 3, 2020
∙ Paid
1
Share

Hi,

As some countries get closer to accessing vaccines to fight the pandemic, it also serves to think about the regulatory processes that make this possible.

In our analyses of the week we take a look back at the regulatory processes around Gilead’s remdesivir and what this tells us about the need for greater convergence among public health authorities.

…

Keep reading with a 7-day free trial

Subscribe to Geneva Health Files to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2023 Priti Patnaik
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing